These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 36111557)

  • 41. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
    Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
    Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors in children less than 6 years of age in the canton of Fribourg, Switzerland (COVPED study): a population-based cross-sectional study.
    Rouge Elton PA; Schmitt PA; Faouzi M; Zimmermann P; Ritter Schenk C
    Swiss Med Wkly; 2022 May; 152():w30173. PubMed ID: 35748747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Families' Worries during the First and Second COVID-19 Wave in Germany: Longitudinal Study in Two Population-Based Cohorts.
    Brandstetter S; Poulain T; Vogel M; Meigen C; Melter M; Köninger A; Apfelbacher C; Kiess W; Kabesch M; Körner A; Kuno Kids Study Group
    Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland.
    Baysson H; Pennachio F; Wisniak A; Zabella ME; Pullen N; Collombet P; Lorthe E; Joost S; Balavoine JF; Bachmann D; Azman A; Pittet D; Chappuis F; Kherad O; Kaiser L; Guessous I; Stringhini S;
    BMJ Open; 2022 Jan; 12(1):e055515. PubMed ID: 35105645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year.
    Hildebrandt A; Hökelekli O; Uflacker L; Rudolf H; Paulussen M; Gatermann SG
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does school reopening affect SARS-CoV-2 seroprevalence among school-age children in Milan?
    Barcellini L; Forlanini F; Sangiorgio A; Gambacorta G; Alberti L; Meta A; Gaia P; Amendola A; Tanzi E; Massa V; Borghi E; Fabiano V; Zuccotti GV
    PLoS One; 2021; 16(9):e0257046. PubMed ID: 34473776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.
    Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H
    BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.
    Valenti L; Bergna A; Pelusi S; Facciotti F; Lai A; Tarkowski M; Lombardi A; Berzuini A; Caprioli F; Santoro L; Baselli G; Ventura CD; Erba E; Bosari S; Galli M; Zehender G; Prati D;
    Blood Transfus; 2021 May; 19(3):181-189. PubMed ID: 33539289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
    Jackson-Thompson BM; Goguet E; Laing ED; Olsen CH; Pollett S; Hollis-Perry KM; Maiolatesi SE; Illinik L; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Davies J; Ortega O; Parmelee E; Lindrose AR; Moser M; Graydon E; Letizia AG; Duplessis CA; Ganesan A; Pratt KP; Malloy AM; Scott DW; Anderson SK; Snow AL; Dalgard CL; Powers JH; Tribble D; Burgess TH; Broder CC; Mitre E
    BMC Infect Dis; 2021 Jun; 21(1):544. PubMed ID: 34107889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection.
    Abu Shanap M; Sughayer M; Alsmadi O; Elzayat I; Al-Nuirat A; Tbakhi A; Sultan I
    Front Immunol; 2022; 13():919762. PubMed ID: 35990639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening".
    Jin DK; Nesbitt DJ; Yang J; Chen H; Horowitz J; Jones M; Vandergaast R; Carey T; Reiter S; Russell SJ; Kyratsous C; Hooper A; Hamilton J; Ferreira M; Deng S; Straus D; Baras A; Hillyer CD; Luchsinger LL
    PLoS One; 2021; 16(4):e0250319. PubMed ID: 33909646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolution of SARS-CoV-2 seroprevalence and clusters in school children from June 2020 to April 2021: prospective cohort study Ciao Corona.
    Ulyte A; Radtke T; Abela IA; Haile SR; Ammann P; Berger C; Trkola A; Fehr J; Puhan MA; Kriemler S
    Swiss Med Wkly; 2021 Oct; 151():w30092. PubMed ID: 34797618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS-CoV-2 seropositivity and COVID-19 among 5 years-old Amazonian children and their association with poverty and food insecurity.
    Ferreira MU; Giacomini I; Sato PM; Lourenço BH; Nicolete VC; Buss LF; Matijasevich A; Castro MC; Cardoso MA;
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010580. PubMed ID: 35849564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
    Stringhini S; Wisniak A; Piumatti G; Azman AS; Lauer SA; Baysson H; De Ridder D; Petrovic D; Schrempft S; Marcus K; Yerly S; Arm Vernez I; Keiser O; Hurst S; Posfay-Barbe KM; Trono D; Pittet D; Gétaz L; Chappuis F; Eckerle I; Vuilleumier N; Meyer B; Flahault A; Kaiser L; Guessous I
    Lancet; 2020 Aug; 396(10247):313-319. PubMed ID: 32534626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-dependent seroprevalence of SARS-CoV-2 antibodies in school-aged children from areas with low and high community transmission.
    Boey L; Roelants M; Merckx J; Hens N; Desombere I; Duysburgh E; Vandermeulen C
    Eur J Pediatr; 2022 Feb; 181(2):571-578. PubMed ID: 34455523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    COVID-19 Cumulative Infection Collaborators
    Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
    Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
    Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases-cross-sectional study from a reference centre in Spain.
    Udaondo C; Millán-Longo C; Permuy C; Valladares L; Falces-Romero I; Muñoz-Gómez C; Morales-Higuera M; Alcobendas R; Remesal A; Murias S; Calvo C
    Clin Rheumatol; 2022 Jun; 41(6):1779-1784. PubMed ID: 35489011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SARS-CoV-2 seroprevalence in children and their family members, July-October 2020, Brussels.
    Dethioux L; Dauby N; Montesinos I; Rebuffat E; Hainaut M
    Eur J Pediatr; 2022 Mar; 181(3):1009-1016. PubMed ID: 34677664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.